Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Inventory (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Change in Inventory for 4 consecutive years, with -$55000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 8.33% to -$55000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137000.0 through Dec 2025, up 389.29% year-over-year, with the annual reading at $137000.0 for FY2025, 389.29% up from the prior year.
  • Change in Inventory for Q4 2025 was -$55000.0 at Orchestra BioMed Holdings, down from $181000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $197000.0 in Q3 2022, with the low at -$60000.0 in Q4 2024.
  • Average Change in Inventory over 4 years is $15125.0, with a median of -$37000.0 recorded in 2022.
  • Peak annual rise in Change in Inventory hit 500.0% in 2024, while the deepest fall reached 850.0% in 2024.
  • Over 4 years, Change in Inventory stood at -$54000.0 in 2022, then surged by 114.81% to $8000.0 in 2023, then crashed by 850.0% to -$60000.0 in 2024, then grew by 8.33% to -$55000.0 in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$55000.0, $181000.0, and $49000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.